Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.
Barnum
S R
SR
Department of Microbiology, The University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. sbarnum@uab.edu
D000818:Animals; D018958:CD55 Antigens / Q000378:metabolism / Q000494:pharmacology; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D003169:Complement Inactivator Proteins / Q000494:pharmacology* / Q000627:therapeutic use; D003165:Complement System Proteins / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D011480:Protease Inhibitors / Q000494:pharmacology; D011951:Receptors, Complement / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism
D018958:CD55 Antigens; D003169:Complement Inactivator Proteins; D011480:Protease Inhibitors; D011951:Receptors, Complement; D003165:Complement System Proteins